More on TNXP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+36.8% Growth)
- Ratings (6.0 Score)
- Holders

Upcoming Events

- Earnings (11/10/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tonix Pharma (NQ:TNXP)
Delayed: 12.71 +0.21 (1.68%)
Prev. Close $12.50  
Open$12.58 
52 Wk High$7.95 
52 Wk Low$0.40 
Day High$12.73 
Day Low$12.08 
P/E N/A  
EPS$-5.33 
Volume348,038 

Friends, Peers and Foes (?): AEMD, CVKD, DYAI, ICU, JAGX (more...)

Aug 14, 2026 08:36 AM Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Sirenia Capital Management LP
Aug 13, 2026 09:18 AM Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: AQR CAPITAL MANAGEMENT LLC
Aug 10, 2026 01:46 PM Tonix Pharma (TNXP) PT Raised to $27 at Raymond James
Aug 10, 2026 08:10 AM Form 10-Q Tonix Pharmaceuticals For: Jun 30
Aug 10, 2026 07:16 AM Form 8-K Tonix Pharmaceuticals For: Aug 10
Aug 10, 2026 07:02 AM Tonix Pharma (TNXP) Tops Q2 EPS by 27c
Aug 10, 2026 07:00 AM Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
Aug 5, 2026 07:00 AM Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 3, 2026 07:05 AM Form 8-K Tonix Pharmaceuticals For: Aug 03
Aug 3, 2026 07:00 AM Tonix gets FDA alignment on Lyme disease antibody study design
View All Articles

Entities mentioned with TNXP

View All Entities